The COVID-19 vaccination acceptance/hesitancy rate and its determinants among healthcare workers of 91 Countries: A multicenter cross-sectional study.
COVID-19
COVID-19 vaccines
HDI
Human Development Index
health personnel
vaccination coverage
Journal
EXCLI journal
ISSN: 1611-2156
Titre abrégé: EXCLI J
Pays: Germany
ID NLM: 101299402
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
10
2021
accepted:
15
12
2021
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinants among healthcare workers in a multicenter study. This was a cross-sectional multi-center survey conducted from February 5 to April 29, 2021. The questionnaire consisted of 26 items in 6 subscales. The English version of the questionnaire was translated into seven languages and distributed through Google Forms using snowball sampling; a colleague in each country was responsible for the forward and backward translation, and also the distribution of the questionnaire. A forward stepwise logistic regression was utilized to explore the variables and questionnaire factors tied to the intention to COVID-19 vaccination. 4630 participants from 91 countries completed the questionnaire. According to the United Nations Development Program 2020, 43.6 % of participants were from low Human Development Index (HDI) regions, 48.3 % high and very high, and 8.1 % from medium. The overall vaccination hesitancy rate was 37 %. Three out of six factors of the questionnaire were significantly related to intention to the vaccination. While 'Perceived benefits of the COVID-19 vaccination' (OR: 3.82, p-value<0.001) and 'Prosocial norms' (OR: 5.18, p-value<0.001) were associated with vaccination acceptance, 'The vaccine safety/cost concerns' with OR: 3.52, p-value<0.001 was tied to vaccination hesitancy. Medical doctors and pharmacists were more willing to take the vaccine in comparison to others. Importantly, HDI with OR: 12.28, 95 % CI: 6.10-24.72 was a strong positive determinant of COVID-19 vaccination acceptance. This study highlighted the vaccination hesitancy rate of 37 % in our sample among HCWs. Increasing awareness regarding vaccination benefits, confronting the misinformation, and strengthening the prosocial norms would be the primary domains for maximizing the vaccination coverage. The study also showed that the HDI is strongly associated with the vaccination acceptance/hesitancy, in a way that those living in low HDI contexts are more hesitant to receive the vaccine.
Identifiants
pubmed: 35221837
doi: 10.17179/excli2021-4439
pii: 2021-4439
pmc: PMC8859647
doi:
Types de publication
Journal Article
Langues
eng
Pagination
93-103Informations de copyright
Copyright © 2022 Askarian et al.
Références
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Vaccines (Basel). 2021 Feb 03;9(2):
pubmed: 33546165
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Expert Rev Vaccines. 2020 Oct;19(10):899-901
pubmed: 32945213
Nature. 2020 Dec;588(7836):16-18
pubmed: 33230278
Vaccines (Basel). 2021 Jul 22;9(8):
pubmed: 34451938
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Lancet. 2021 Jan 9;397(10269):72-74
pubmed: 33306990
EXCLI J. 2021 Mar 15;20:661-664
pubmed: 33883990
Nature. 2020 Nov;587(7834):337-338
pubmed: 33199901
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Int J Infect Dis. 2021 Aug;109:286-293
pubmed: 34242765
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
Int J Equity Health. 2021 Aug 14;20(1):183
pubmed: 34391416
Front Immunol. 2020 Oct 14;11:585354
pubmed: 33163000
J Cosmet Dermatol. 2019 Dec;18(6):1700-1704
pubmed: 30920111
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006